EZN

Related by string. * * *

Related by context. All words. (Click for frequent words.) 71 Seliciclib 70 PSMA ADC 70 PEG SN# 70 oral prodrug 70 OMP #M# 69 Aurora Kinase 69 CYC# 69 CDK inhibitor 69 pan HDAC inhibitor 69 PNP inhibitor 69 selective modulator 69 orally administered inhibitor 69 MEK inhibitor 69 liposomal formulation 68 PKC# 68 selective inhibition 68 Voreloxin 68 CCX# 68 RhuDex ® 68 Omacetaxine 68 CYT# potent vascular disrupting 68 huN# DM1 68 Zevalin R Ibritumomab 68 AAG geldanamycin analog 68 IAP inhibitor 68 Factor VIIa 68 5 HT2C receptor 68 Gleevec resistant 68 Elvitegravir 68 polymerase inhibitor 68 selective kinase inhibitor 68 huC# DM4 68 HSP# inhibitor 67 targeted radiotherapeutic 67 Epidermal Growth Factor Receptor 67 Pertuzumab 67 TKB# 67 non nucleoside inhibitor 67 Xanafide 67 radiation sensitizer 67 mertansine 67 Gastrointestinal Stromal Tumors 67 Prolongs Survival 67 signal transduction inhibitor 67 ENMD # 67 Liposomal 67 alpha folate receptor 67 Fulvestrant 67 Alocrest 67 Bortezomib 67 nucleoside analog 67 Panzem R 67 proteasome inhibitor 67 histone deacetylase inhibitor 67 orally dosed 67 immunoconjugate 67 Antiangiogenic 67 vidofludimus 67 AKT inhibitor 67 Sym# 67 IMiDs ® 67 Vidofludimus 67 OXi# 67 humanized anti 67 potent topoisomerase II 67 Thrombin 67 dasatinib Sprycel 67 histone deacetylase HDAC inhibitor 67 LHRH 67 Ecallantide 66 Milatuzumab 66 hypoxia inducible factor 66 Hsp# Inhibitor 66 PI3K inhibitor 66 Aurora kinase 66 PDE4 inhibitor 66 Aplidin R 66 AEG# 66 Kinase Inhibitor 66 VEGF receptor 66 nucleotide analog 66 Preclinical studies suggest 66 CBLC# 66 Trofex TM 66 PEGylated Fab fragment 66 Alfacell proprietary ribonuclease 66 TLR9 agonist 66 Cannabinor 66 rhIL 7 66 novel peptide 66 oral proteasome inhibitor 66 preclinically 66 fosbretabulin 66 MAGE A3 ASCI 66 novel orally bioavailable 66 depsipeptide 66 peripherally acting 66 evaluating tivozanib 66 Tyrosine Kinase Inhibitor 66 CR# vcMMAE 66 novel topoisomerase 66 Advanced Renal Cell 66 2 methoxyestradiol 66 Aliskiren 66 Bavituximab 66 mapatumumab 66 XYOTAX TM 66 estramustine 66 novel VDA molecule 66 CA4P 66 GW# [003] 66 HCV protease inhibitor 66 Peginterferon alfa 2b 66 CEQ# 66 OMP #R# 66 somatostatin analogue 66 Oritavancin 66 Tumor Necrosis Factor 66 cyclin dependent kinase inhibitor 66 Camptothecin 66 multikinase inhibitor 66 Monoclonal Antibody 66 HER1 66 stable nucleic acid 66 #ME# 66 docetaxel Taxotere ® 65 Phase 2a Clinical Trial 65 intravesical instillation 65 CYP#A# CYP#D# 65 pathophysiological effects 65 enzyme inhibitor 65 ALN TTR 65 Aflibercept 65 Blinatumomab 65 chemokine receptor 65 HGS ETR2 65 Pathway Inhibitor 65 oral Janus kinase 65 immunostimulatory 65 Enzastaurin 65 Irinotecan 65 alkylating agent 65 thymidylate synthase TS 65 cyclin dependent kinase CDK 65 LHRH antagonist 65 mda 7 65 selective agonist 65 Talabostat 65 cetuximab Erbitux R 65 luteinizing hormone releasing 65 small molecule Hedgehog 65 Chemokine Receptor 65 selective antagonist 65 rxRNA 65 Locked Nucleic Acid LNA 65 5 lipoxygenase 65 Oral Fingolimod 65 YONDELIS 65 HER3 65 anti amnesic 65 Tezampanel 65 JAK1 65 vorinostat 65 MGd 65 non nucleoside HCV 65 EndoTAG TM -1 65 gemcitabine cisplatin 65 Onconase 65 plasma kallikrein inhibitor 65 Receptor Antagonists 65 Panzem R NCD 65 Daclizumab 65 EGFR HER2 65 Janus kinase 65 sulindac 65 alfa 2a 65 androgen receptor AR 65 CD# CEA 65 polymerase inhibitors 65 pomalidomide 65 receptor blocker 65 sorafenib tablets 65 Etoposide 65 selectively inhibits 65 topoisomerase II inhibitor 65 cMET 65 Traficet EN 65 Varespladib 65 Symadex 65 ganetespib 65 K ras mutations 65 tezampanel 65 TNFalpha 65 dasatinib Sprycel ® 65 talabostat 65 VELCADE melphalan 65 protein tyrosine phosphatase 1B 65 Trastuzumab 65 virus HCV protease inhibitor 65 oral Hsp# inhibitor 65 Decitabine 65 potent antiproliferative 65 Novel Oral 65 NEUGENE 65 HER2 ErbB2 65 Anticalins ® 65 Golimumab 65 Protease Inhibitor 65 investigational humanized monoclonal antibody 65 Kahalalide F 65 xenograft models 65 hypoxia selective 65 INCB# [001] 65 Romidepsin 65 pharmacokinetic interactions 65 Ozarelix 65 Darinaparsin 65 thrombin receptor 65 Protein Kinase C 65 protein kinase inhibitor 65 Perifosine 65 5 FU leucovorin 65 Intravenous CP 65 Factor Receptor 65 replicon 64 PRT# 64 Meets Primary Endpoint 64 dexamethasone Decadron 64 SinuNase ™ 64 IMiDs R 64 Capecitabine 64 cathepsin K inhibitor 64 Preclinical studies 64 microtubule inhibitor 64 KSP inhibitor 64 Elotuzumab 64 HCV NS3 protease 64 Glufosfamide 64 DiLA2 64 galiximab 64 chimeric monoclonal antibody 64 targeting CD# 64 immune modulatory 64 Sapacitabine 64 humanized monoclonal 64 EGFR TKI 64 Mg Usa 64 MAb 64 HDAC Inhibitor 64 Pralatrexate 64 molecularly targeted 64 Degarelix 64 Panzem 64 sitaxsentan 64 relapsed MM 64 novel orally administered 64 CCR2 64 vinca alkaloid 64 thalidomide Thalomid 64 Interferon alpha 64 uricase 64 cannabinor 64 Bezielle 64 64 anti angiogenic agent 64 T#I [002] 64 investigational protease inhibitor 64 receptor modulators 64 novel tubulin binding 64 siRNA therapeutic 64 Azacitidine 64 Belerofon 64 metaglidasen 64 myelofibrosis polycythemia vera 64 Lubiprostone 64 pegylated liposomal doxorubicin 64 R roscovitine 64 targeted antifolate 64 Universal Flu Vaccine 64 Cloretazine 64 interferon γ 64 Phase 2b Clinical Trial 64 Adefovir 64 MTP inhibitor 64 receptor tyrosine kinase inhibitor 64 Phase IIb Clinical Trial 64 NS5B polymerase 64 administered subcutaneously 64 Natalizumab 64 ERK1 2 64 anti CD3 64 Immunotherapeutic 64 nanomolar 64 humanized antibody 64 NS#/#A protease 64 orally bioavailable 64 HCV replicon 64 antisense oligonucleotide 64 5 HT2A inverse 64 Fenretinide 64 Interferon Beta 64 non nucleoside 64 TNF Tumor Necrosis Factor 64 Antitumor Activity 64 Tesmilifene 64 novel histone deacetylase 64 CB2 selective receptor agonist 64 Exemestane 64 XmAb ™ 64 chemically modified siRNA 64 Dalbavancin 64 Rigel R# 64 PDE4 64 poly ADP ribose polymerase 64 DNA intercalator 64 Tyrima 64 Thiarabine 64 IL# PE#QQR 64 KRN# 64 NMDA antagonist 64 PEGPH# 64 DermaVir Patch 64 peptidic compound 64 Recombinant Human 64 ALN TTR# 64 mecamylamine 64 PEGylated anti 64 muscarinic 64 methionine aminopeptidase 64 FOLOTYN ® 64 effector function 64 systemic antifungal 64 Methylnaltrexone 64 Peginterferon 64 cyclophosphamide methotrexate 64 REP# 64 OMNARIS Nasal Spray 64 hormone LHRH antagonist 64 5 HT6 receptor 64 radiolabeled 64 Elagolix 64 rFSH 64 radiolabeled monoclonal antibody 64 imatinib Gleevec 64 Tarvacin 64 IFN beta 64 cytoprotective 64 Dasatinib 64 sunitinib Sutent ® 64 MORAb 64 cortisol synthesis 64 erlotinib Tarceva ® 64 TRO# 64 Cetrorelix pamoate 64 Safinamide 64 beta 1a 64 GAP #B# 64 platform HDL Mimetic 63 small molecule defensin 63 CCR5 antagonist 63 intravenously administered 63 thymalfasin 63 5 HT2A receptor 63 Apoptone 63 nucleoside reverse transcriptase inhibitor 63 small molecule tyrosine 63 renin inhibitor 63 accumulate preferentially 63 Pharmacokinetics PK 63 histone deacetylase HDAC 63 oral antiviral 63 generation purine nucleoside 63 Ocrelizumab 63 prostanoid 63 adalimumab Humira 63 Ixabepilone 63 FGFR3 63 HQK 63 peptidomimetic 63 novel immunomodulatory 63 proteasome inhibitors 63 Nanobody 63 Therapeutic Vaccine 63 survivin 63 vitro cytotoxicity 63 ADP receptor antagonist 63 ISTODAX 63 PI3K/Akt pathway inhibitor 63 anionic backbone 63 vapreotide acetate 63 Maribavir 63 GRNVAC1 63 Nucleoside 63 indibulin 63 Archexin 63 MT# MEDI 63 metastatic malignant 63 RhuDex R 63 liposome encapsulated 63 MCSP respectively 63 systemically administered 63 immunotoxin 63 Albuferon TM 63 RNAi Therapeutic 63 IFN α 63 mGluR2 NAM 63 topically administered 63 Tarceva TM 63 RNA antagonist 63 ON #.Na 63 Doxorubicin 63 immunomodulator 63 IL 1ß 63 induces apoptosis 63 p# inhibitor 63 Bendamustine 63 Androgen Receptor 63 XL# anticancer compounds 63 5 HT4 63 Tamibarotene 63 antiangiogenic activity 63 delafloxacin 63 Fondaparinux 63 compound AEZS 63 tyrosine kinase inhibitor TKI 63 Elesclomol 63 HGS ETR1 mapatumumab 63 SERMs 63 c MYC 63 Ontak 63 TRAIL R2 63 HCV protease 63 IAP inhibitors 63 Annexin V 63 tyrosine kinase inhibitor 63 lexidronam injection 63 gefitinib Iressa 63 multi kinase inhibitor 63 5 Fluorouracil 63 Mucosal 63 glucagon receptor 63 Hycamtin ® 63 FAAH 63 sorafenib Nexavar 63 vascular disrupting agents 63 Preclinical Data 63 Cytochrome P# 63 CD# monoclonal antibody 63 CORT # 63 Crizotinib 63 liposomal 63 cytostatic 63 synthetic siRNA 63 busulfan 63 volociximab 63 AMD# [003] 63 Tarvacin TM 63 prodrug 63 peptide conjugated 63 CCR9 63 Forodesine 63 intranasal formulation 63 mTOR mammalian target 63 tiapamil 63 idarubicin 63 taxane derivative 63 intravesical infusion therapy 63 Tesetaxel 63 antiproliferative activity 63 antisense compounds 63 T#M 63 Sudhir Agrawal D.Phil 63 JAK Inhibitor 63 pharmacokinetic properties 63 liposomal doxorubicin 63 antisense drug 63 angiogenesis inhibitor 63 JAK3 63 tumor xenograft models 63 Radezolid 63 HGS ETR1 63 Omacetaxine mepesuccinate 63 Vidaza azacitidine 63 Linaclotide 63 cleavable linker 63 ceftazidime 63 camptothecin 63 selectively inhibited 63 antiangiogenic 63 Parathyroid Hormone 63 NS5b 63 CD4 monoclonal antibody 63 vinca alkaloids 63 Amrubicin 63 PEG IFN 63 Granulocyte Colony Stimulating Factor 63 MGCD# [001] 63 novel prodrug 63 Cyclooxygenase Inhibiting Nitric Oxide 63 JAK2 Inhibitor 63 DAVANAT 63 systemic RNAi therapeutic 63 interleukin IL -# 63 Lenalidomide 63 triciribine phosphate monohydrate 63 JAK#/JAK# 63 EGFr 63 Microplasmin 63 5 HT2A serotonin 63 agonistic human 63 FUS1 63 Preclinical Study 63 Antiviral Activity 63 long acting muscarinic 63 Ganciclovir 63 TNFα 63 Zysolin TM 63 Litx 63 FGFR 63 IGF1R 63 AQ4N 63 dihydrofolate reductase 63 amprenavir 63 Anthracycline 63 delta opioid receptor 63 Solazed TM 63 immunomodulating 63 colon carcinoma 63 seliciclib CYC# 63 Fleximer 63 apoptosis inducer 63 Nilotinib 63 Taxol ® 63 antisense inhibitor 63 ghrelin receptor 63 subcutaneously administered 63 Angiotensin 63 tumor necrosis 63 PORxin TM 63 Tocilizumab 63 pharmacodynamic profiles 63 recurrent glioblastoma multiforme 63 ATL# [001] 63 aurora kinase 63 vascular disrupting agent 63 CTAP# Capsules 63 IFN ß 63 XOMA 3AB 63 GHRH 63 ALN HPN 63 anticancer compound 63 LT NS# 63 nilotinib Tasigna ® 63 interleukin IL 63 RAV# 63 MYDICAR ® 63 ISF# 63 phosphate S1P 63 Antitumor 63 TG# [003] 63 antibody MT# 63 Anticalins R 63 vinorelbine tartrate 63 AEGR 63 Nexavar sorafenib 63 IMMU 63 NS4A 63 PEGylated 63 IMC A# 63 Aptamer 63 D aspartate NMDA receptor 63 Capesaris 63 azacytidine 63 Tubulin 63 inducible nitric oxide synthase 63 CCR1 63 antiproliferative effects 62 Cethromycin 62 LY# [003] 62 ANG# 62 verteporfin 62 2A receptor agonist 62 acetylcholinesterase AChE 62 antibody MAb 62 JVRS 62 Clusterin 62 recombinant FVIII 62 Immunohistochemical analysis 62 selective adenosine 62 5HT 62 EXPAREL TM 62 BMS # 62 proprietary polysaccharide 62 Perifosine KRX 62 Tasimelteon 62 aurora kinase inhibitor 62 Ad5FGF 4 62 antiapoptotic 62 mTOR inhibitors 62 E#F# 62 Inhalation Solution 62 Orally administered 62 Enhanze Technology 62 Panzem NCD 62 Myocet 62 ATL/TV# 62 Ofatumumab 62 sphingosine 1 62 CD3 monoclonal antibody 62 Octreotide 62 AMPK activators 62 GRN# 62 small molecule thrombopoietin 62 antidiabetic 62 factor Xa inhibitor 62 Gamma secretase 62 selective estrogen receptor modulator 62 timolol 62 Completes Patient Enrollment 62 VNP#M 62 factor G CSF 62 OncoVEX GM CSF 62 PDX pralatrexate 62 Immunomodulatory 62 Silodosin 62 DFMO 62 seliciclib 62 annexin V 62 class anticancer quinolone 62 Epothilones 62 Bevacizumab 62 Temsirolimus 62 PROSTASCINT R 62 HTS assay 62 tubulin inhibitor 62 PXD# 62 Pemetrexed 62 ocular formulation 62 topical ophthalmic 62 rHuPH# 62 Oral NKTR 62 short interfering RNA 62 Signaling Pathway 62 Phase 1b clinical trials 62 chemotherapy induced neutropenia 62 Janus Kinase 62 somatostatin analog 62 Cyclin E 62 Angiotensin Converting Enzyme 62 brivanib 62 ABRAXANE ® 62 Novel Mechanism 62 immune stimulatory 62 UsiRNAs 62 Pazopanib 62 ANAVEX #-# [001] 62 oncolytic vaccine 62 potently inhibit 62 siRNA mediated 62 reversible inhibitors 62 murine monoclonal antibody 62 mitogen activated ERK kinase 62 Epratuzumab 62 Velcade bortezomib 62 immunomodulatory 62 bevacizumab Avastin R 62 Presents Preclinical Data 62 APOPTONE 62 intratumoral injection 62 Anti Tumor 62 alpha TNFa 62 XL# XL# 62 subcutaneous SC 62 selective androgen receptor modulator 62 binds selectively 62 HIF PH inhibitors 62 histamine dihydrochloride 62 VA# [002] 62 polysaccharide polymer 62 generation nucleoside analog 62 NK1 62 polyglutamate 62 M2 subunit 62 GMX# 62 potent suppressor 62 agonist compounds 62 Mg Uk 62 ALK inhibitor 62 urocortin 2 62 Amplimexon 62 vWF 62 C5aR 62 Pafuramidine 62 Polymerase Inhibitor 62 TNF receptors 62 antiandrogen 62 Anticalin ® 62 LY# [002] 62 bortezomib Velcade 62 AMN# [001] 62 Anti Bacterial Envelope 62 Oligonucleotide 62 TNF α 62 Fc fusion protein 62 IL 1beta 62 adefovir dipivoxil 62 5 fluorouracil leucovorin 62 XL# XL# XL# 62 Cloretazine ® 62 Allogeneic 62 JAK inhibitor 62 deCODE chemistry 62 microtubule targeting 62 radiotherapeutic 62 mouse xenograft models 62 serine protease 62 FasL 62 Guanilib 62 Bafetinib 62 decitabine 62 anti fibrotic 62 CCR5 mAb 62 EGF receptor 62 Imatinib 62 factor HGF 62 Darusentan 62 alvespimycin 62 Familial Adenomatous Polyposis FAP 62 mitogen activated protein kinase 62 G Protein Coupled 62 nicotinic acetylcholine receptor 62 uPA 62 CIMZIA TM 62 Metastatic Melanoma 62 FUSILEV enhances 62 oral picoplatin 62 acetonide FA 62 irreversible inhibitor 62 II Clinical Trial 62 hTERT 62 TNFa 62 TRAIL receptor 62 histone deacetylase inhibitors 62 PDGF receptor 62 octreotide acetate 62 triphendiol 62 oblimersen 62 Phase III Pivotal 62 c MET 62 virus AAV 62 Beta catenin pathway 62 Eg5 62 chemotherapeutic drug 62 VEGFR2 inhibitor 62 polycythemia vera PV 62 Nexavar ® 62 radezolid 62 peripherally restricted 62 CTCE 62 CANCIDAS 62 BAL# [001] 62 TAFA# 62 paclitaxel Taxol ® 62 S#P# 62 LEP ETU 62 cytokines IL 62 PrevOnco 62 demonstrated antitumor activity 62 Cathepsin S 62 antisense oligonucleotides 62 pertuzumab 62 Randomized Phase 62 Small Molecule 62 VEGFR2 62 2 inhibitor CYT# 62 Trofex 62 Cyclooxygenase 2 62 MET VEGFR2 62 EOquin TM 62 highly selective inhibitor 62 IMiDs ® compound 62 AMPA kainate 62 perifosine KRX 62 sodium glucose cotransporter 62 vitro assay 62 dexpramipexole 62 humanized monoclonal antibody 62 BAY #-# 62 potently inhibited 62 First Patient Dosed 62 CCX# B 62 KSP inhibitors 62 GnRH antagonist 62 HIF 1alpha 62 BiTE 62 TBC# 62 PARP inhibitor 62 oral dihydropyrimidine dehydrogenase DPD 62 VAPRISOL 62 SYN# 62 androgen independent 62 anaplastic lymphoma kinase ALK 62 caspofungin 62 Anticalin R 62 trastuzumab Herceptin R 62 Platinol ® cisplatin 62 Ridaforolimus 62 Zolinza 62 goserelin 62 JAK2 enzyme 62 Everolimus 62 telaprevir VX 62 TO AVOID PREGNANCY WHILE 62 P#X# 62 apoptosis proteins 62 Systemic Delivery 62 compound PMX # 62 mineralocorticoid receptor 62 rilonacept 62 MET amplification 62 Teriparatide 62 pharmacodynamic profile 62 forodesine 62 paclitaxel Taxol 62 daunorubicin 62 Cardiotoxicity 62 ONCASPAR 62 Onalta 62 Thiovir 62 INCB# [003] 62 receptor inhibitor 62 Angiolix 62 delta isoform 62 Anavex #-# 62 small molecule chemotherapeutic 62 bendamustine 62 cytidine 62 direct thrombin inhibitors 62 ritonavir boosted 62 Vitro Activity 62 Phase III Clinical Trial 62 bevacizumab Avastin ® 62 Exelixis XL# 62 selectively binds 62 Receptor Agonist 62 ARIKACE 62 RAS MAPK pathway 62 AZT zidovudine Retrovir 62 mediated apoptosis 62 PD LID 62 Bruton tyrosine kinase 62 antifibrotic 62 peptide antigens 62 anticancer agent 62 Civacir 62 Alkeran 62 Telbivudine 62 amikacin 62 mGluR5 NAM 62 NXL# 62 HCV RESPOND 2 62 novel anticancer 62 LEUKINE 62 Protelos R 62 gonadotropin releasing hormone GnRH 62 delivered RNAi therapeutic 62 lanreotide 62 Qutenza TM 62 Camptosar ® 62 tkRNAi 62 inhibitor RG# 62 AtuRNAi 62 XL# inhibits 62 Nanobody ® 62 Cathepsin B 62 hyaluronidase enzyme 62 ACC2 62 Androxal TM 62 N methyl 62 alkylating 62 adenoviral 62 mRNA antagonists 62 siRNA binds 62 p# mitogen activated 62 PSN# [001] 62 thromboxane A2 62 PGL# 62 SPRYCEL ® 61 Interferon alfa 61 echinocandin 61 PI3 Kinase 61 Personalized Immunotherapy 61 cyclic peptide 61 FluCide 61 telaprevir dosed 61 Neulasta ® 61 docetaxel Taxotere R 61 bispecific 61 gonadotrophin releasing hormone GnRH 61 5 HT3 antagonist 61 M1 muscarinic 61 Vidaza ® 61 Afatinib 61 Secretase 61 HepG2 cells 61 Myolimus 61 HCV protease inhibitors 61 active moiety 61 secretory phospholipase A2 sPLA2 61 Azedra 61 MKC# MT 61 Doxil ® 61 heparanase 61 inhibit oxidative stress 61 pharmacodynamic properties 61 PI3K/mTOR 61 morpholino 61 Tumor Response 61 tafamidis 61 topical gel formulation 61 LEX System 61 Vaprisol 61 Triapine R 61 milatuzumab 61 Initiate Phase 61 Anidulafungin 61 sulfonylhydrazine class 61 Phase Ib study 61 chemokine receptors 61 Ataluren 61 CDDO Im 61 Zalypsis 61 receptor partial agonist 61 Boceprevir 61 Y2 receptor 61 cyclin dependent kinases CDKs 61 cell lymphoma CTCL 61 Proteasome 61 Cutaneous T 61 ImmunoVEX HSV2 61 antitumor efficacy 61 FOLFOX6 61 VQD 61 Onalta TM 61 CIMZIA ™ 61 Prodrug 61 Novel Therapeutic 61 investigational immunotherapy 61 alefacept 61 FLT3 61 tegafur 61 Iloperidone 61 mGluR5 negative 61 Fludarabine 61 Anti TNF 61 ELACYT 61 Gemcitabine 61 Abstract Number 61 Dendritic Cells 61 elotuzumab 61 Carfilzomib 61 small molecule activator 61 pharmacodynamic PD 61 defensin mimetic antibiotic 61 granisetron 61 Eculizumab 61 PCK# 61 Cloretazine R 61 ERK phosphorylation 61 A3 adenosine receptor 61 Interferon beta 1a 61 oncolytic 61 omega interferon 61 OvaRex R 61 ErbB3 61 estrogen receptor antagonist 61 TET2 61 Chronic Lymphocytic Leukemia CLL 61 Fidaxomicin 61 1beta 61 pDC 61 generation antisense inhibitor 61 PEGylated interferon 61 mTOR inhibitor 61 Cytotoxic T 61 AeroLEF TM 61 fluoropyrimidine 61 ATL# [002] 61 Topotecan 61 Ceflatonin R 61 MT#/MEDI-# 61 Laquinimod 61 Vinorelbine 61 gemcitabine Gemzar ® 61 PSN# [002] 61 DXL# 61 ribavirin RBV 61 hepatoma 61 Teriflunomide

Back to home page